Ricerca avanzata

Mathieu Lamy occupa la posizione di Chief Operating Officer & Executive Vice President presso Intact Financial Corp. È anche vicepresidente senior per i reclami presso Intact Insurance. In precedenza è stato Chief Information Officer & Senior Vice President per IntAct Labs LLC, Executive Vice President-Operations per AXA Life Insurance (Canada) e Executive Vice President di AXA Canada, Inc. Il sig. Lamy si è laureato presso la Universit Laval.

Mr. Mathieu Bonnet is a Chairman at E6 SAS, a Chief Executive Officer & Director at Allego BV, a Chief Executive Officer & Director at Allego NV, a Chief Executive Officer at Allego BV (New) and a President at Spartan Acquisition Corp.
III.
He is on the Board of Directors at Allego BV and Allego NV.
Mr. Bonnet was previously employed as a Chief Executive Officer by Compagnie Nationale du Rhône.
He received his undergraduate degree from Ecole Polytechnique, a graduate degree from École Nationale Supérieure des Mines de Paris and a graduate degree from Université Catholique de Louvain.

Mathieu Simon è presidente di Epsilen Bio SRL, presidente di Idorsia Ltd., amministratore indipendente di Asarina Pharma AB, amministratore indipendente di Vaximm AG, presidente di Idorsia Pharmaceuticals Ltd., amministratore delegato di Cellectis Therapeutics e amministratore indipendente di LNC Therapeutics SA. Fa parte del Consiglio di amministrazione di Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associs SCA e LNC Therapeutics SA. Il Dr. Simon è stato precedentemente impiegato come EVP, Chief Operating & Medical Officer di Cellectis SA, Vicepresidente di Marketing & Medical Affairs di Wyeth Pharmaceuticals LLC, Group VP-Marketing & Clinical Affairs di Wyeth-Ayerst International, Inc., Senior Vice President-Global Operations di Pierre Fabre Mdicament SAS, Managing Director & Head-Global Pharma di Pierre Fabre SA e Chairman & Chief Executive Officer di Takara Bio Europe AB. È stato anche membro del consiglio di amministrazione di Alliance for Regenerative Medicine, Ectycell SASU e Farmindustria.

Mathieu Bernard Streiff is the founder of American Healthcare Investors LLC, which was founded in 2011.
He held the title of General Counsel & Managing Director at the firm from 2011 to 2019.
Mr. Streiff's current jobs include being a Director at Hawkhill House Ltd.
since 2016, a Director at American Healthcare REIT, Inc. since 2015, a Director at GAHC3 U.K.
Senior Care Holding Ltd., a Director at Coniston Care Centre Ltd.
since 2016, a Director at Orchard St Albans Housing Portfolio Ltd.
since 2015, a Member of the New York State Bar Association, an Executive Vice President at Griffin-American Healthcare REIT Sub-Advisor, LLC since 2012, and an Executive Vice President at Griffin-American Healthcare REIT III Advisor LLC since 2012.
Mr. Streiff's former jobs include being a Director at Trilogy Investors LLC, Executive Vice President & General Counsel at Grubb & Ellis Co. from 2010 to 2011, Executive Vice President & General Counsel at Griffin-American Healthcare REIT II, Inc. from 2012 to 2014, Executive Vice President & General Counsel at Griffin-American Healthcare REIT III, Inc. from 2013 to 2021, an Associate at Latham & Watkins LLP from 2002 to 2006, Secretary, Executive VP & General Counsel at Grubb & Ellis Realty Investors LLC in 2011, and Executive Vice President at Griffin American Healthcare Reit Advisor LLC from 2011 to 2014.
Mr. Streiff's education includes an undergraduate degree from the University of California, Berkeley and a graduate degree from Columbia Law School.

Attualmente, Mathieu Vrijsen occupa la posizione di presidente del consiglio di sorveglianza di Casco Phil, presidente del consiglio di sorveglianza di Broadview Holding BV e presidente del consiglio di sorveglianza di Corbion NV. Vrijsen fa anche parte del consiglio della Camera di commercio svizzero-americana, dell'Associazione europea per le bioindustrie, di Desso BV e di Joma Sport BVBA ed è membro del comitato esecutivo dell'Istituto internazionale per lo sviluppo del management. Nella sua carriera passata ha ricoperto la posizione di Senior Vice President-Operations & Engineering alla E.I. du Pont de Nemours & Co.

Mathieu O. Floreani è presidente del consiglio di amministrazione e CEO di Synlab AG, co-amministratore delegato di LS Medizin Service GmbH, amministratore delegato del gruppo SYNLAB International GmbH e co-amministratore delegato di Medizinisches Versorgungszentrum SYNLAB Leverkusen GmbH. Fa parte del Consiglio di amministrazione di Synlab Diagnsticos Globales SA, ALcontrol Group Ltd., Labco UK Group Ltd. e SYNLAB Ltd. Il signor Floreani è stato precedentemente impiegato come presidente, amministratore delegato e direttore di DHL Global Forwarding North America e come amministratore delegato di SYNLAB Medizinisches Versorgungszentrum Stuttgart GmbH.

Veronique Lamy has worked as the Director of Human Resources at Eurogerm SA since 1989.

Ms. Megan H.
Lamy is a Director-Marketing & Advertising at NextCare, Inc. Ms. Lamy was previously employed as a Principal by AIR Marketing, Inc., a Principal by Alaska Airlines, Inc., and a Principal by Comprehensive Medical Imaging, Inc. She received her undergraduate degree from Arizona State University and an MBA from Arizona State University.

Dr. Thomas Lamy is a Director & Vice President at Biosynex SA, a Chairman at A.J.T.
Financière SAS, a Chief Executive Officer & Director at Biosynex Premier SA, a Chief Executive Officer & Director at Biosynex Swiss SA and a Sales Manager at PBS Orgenics.
He is on the Board of Directors at Biosynex SA, Biosynex Premier SA and Biosynex Swiss SA. Dr. Lamy was previously employed as a Chief Executive Officer by Dectra Pharm SAS and a Chairman & Managing Director by All Diag.
He also served on the board at Theradiag SA. He received his MBA from École des Hautes Études Commerciales de Paris and a doctorate degree from the Institut National Polytechnique de Lorraine.

Christophe Lamy has been the General Manager at Envea SA since 2001.

Tiphanie Lamy is currently the Deputy Managing Director at FLCP & Associés SASU and FLCP & Associes Invest SAS.
She is also a Member-Supervisory Board at Focus Entertainment SA. Previously, she worked as a Director at Tuvalu Media Netherlands BV.

Esdra Lamy currently works at Airline Passenger Experience Association, Inc., as Director.

Sebastien Lamy is currently the Managing Director at Keppel Technology & Innovation Pte Ltd.
Prior to this, he worked as the Director-Group Strategy & Development at Keppel Ltd.
and as a Director at M1 Ltd.

Laurence Lamy currently works as a Manager of Corporate Communications at Mersen SA.

Yasemin Lamy joined British International Investment as Deputy CIO in August 2018.
She is responsible for the Catalyst Strategies, a portfolio aimed at transformational, system-level impact and innovation across its target geographies of Africa and South Asia.
Prior to British International Investment, she spent three years building two new portfolios for Omidyar Network: one portfolio to develop empowering digital identity technologies and one portfolio to establish a trendspotting capability.
Previously, she worked across several different roles within capital markets at J.P.
Morgan, starting out in fund-linked derivatives and then as a credit derivatives analyst, before building and leading the impact investment platform for the firm.
Yasemin has published widely and provided expert advice to the OECD, World Economic Forum and others.
She holds a Masters in Financial Mathematics from King’s College, London and a Bachelor in Mathematics and Philosophy from the University of Pennsylvania.

Donzé Aurélia Lamy worked as a Portfolio Manager at Edmond de Rothschild Asset Management (Suisse) SA from 2009 to 2015.

Hubert Lamy has a current job as a Director at ATIC Services SAS.

Mr. Arnaud-Guilhem Lamy is a Head of Euro Aggregate Bond Management Strategies at BNP Paribas Asset Management Europe SAS.
He is responsible for euro-aggregate's bond management strategies and is also an expert in socially responsible investment (SRI) for bond management.
Prior to joining BNP Paribas Asset Management in 2010, he was Eurobond Portfolio Manager at Fortis Investments in London (2007-2010), responsible for ABS and covered bonds.
He was a credit analyst at Société Générale Asset Management (2005-2007), after starting his career at Crédit Foncier de France in 2001 as a securitisation specialist.
He graduated in Finance and Economics from the Ecole Nationale de la Statistique et de l'Administration Economique (ENSAE, France, 2001).
He also holds a Master's degree in Applied Mathematics from Dauphine University (Paris, France, 1999).

Edouard Lamy is a member of the IT team, specialising in venture deals.
Before joining Apax Partners in August 2003, he worked for three years in the London office of Crescendo Ventures, a global venture capital firm headquartered in California and concentrating on early stage investments in information technology companies.
He previously worked as a business development manager at World Telecom labs, a Brussels-based communications technology company, developing advanced carrier switching equipment solutions.
Prior to that, he spent two years as an investment analyst in New York at SG Capital Partners.
Edouard graduated from Ecole Superieure de Commerce de Paris in 1997.

Caroline Lamy is currently working as the Co-Head of Equity Management at Crédit Mutuel Asset Management SA since 2021.
Previously, she worked as an Analyst at ING Belgium SA (France) in 2001.

Alina Lamy is a Senior Analyst at Morningstar, Inc. (Research).
She completed her undergraduate degree at Illinois Institute of Technology.

Olivier Lamy is currently a Director at Pobi Industrie SA, Pobi Charpentes SA, Perform Habitat SAS, La Barrade SNC, and AST Services SAS.
He previously worked as a Director-Administrative & Finance at A.S.T.
Groupe SA from 2013 to 2016 and as a Senior Manager at Arthur Andersen & Cia from 2001 to 2002.
Mr. Lamy obtained his undergraduate degree from ESCP Europe Campus Paris in 1998 and Burgundy School of Business in 1998.

Marc Lamy has held positions as an Independent Non-Executive Director at Alliances Developpement Immobilier SA and as a Founding Member at Institut Français Des Administrateurs.

Bernard Lamy currently works as a Director at Sarcelles Energie SA.

Tristan Lamy currently works as the Chief Executive Officer and Director at Alenis SA.

David Lamy currently works at Tradecowall SCRL, as Chief Executive Officer from 2016, Recynam NV, as Managing Director from 2010, and Recyhoc NV, as Director from 2016.

Kenneth S.
Lamy is the founder of The Lamy Group Ltd.
He is currently working as a Director at the National Association of Real Estate Cos.

Jean-Lucien Lamy is currently the Chief Executive Officer at FCI USA LLC.
Prior to this, he worked as a Director at Aliaxis SA.

Elaine M.
Lamy currently works as a Development Director at Engaging Schools, Inc.

Maxim Saint-Amant Lamy worked as the Chief Compliance Officer & Operations Manager at Nymbus Capital, Inc. from 2019 to 2020.
He received his undergraduate and graduate degrees from HEC Montréal.

Mr. Philippe Lamy is Co-Founder & Partner at AlphaOne Partners LLP.
He previously worked at Goldman Sachs.

Franck Lamy has worked as an Investment Manager at Demeter Ventures SA since 2014.

Pascal Lamy is currently the Director at Thomson Reuters Founders Share Co., Ltd., the Director at Centre on Regulation in Europe, a Professor at China Europe International Business School, and the President-Emeritus at Jacques Delors Institute.
He was formerly the Director General at the World Trade Organization.

Patrick Lamy's career history includes current and former positions as well as education.
Currently, he is the Senior Vice President-Commercial Strategy at Akero Therapeutics, Inc. Previously, he worked at Gilead Sciences, Inc. as the Head-Commercial Strategy & Banking from 2008 to 2018, and at Iovance Biotherapeutics, Inc. as the Vice President-Commercial from 2018 to 2021.
In terms of education, Mr. Lamy holds an MBA from the University of California, Berkeley, and an undergraduate degree from the University of California San Diego.

Mr. Gérard Lamy is a Director-Research at Wendel SA and a Member at The French Society of Financial Analysts.
He received his undergraduate degree from École des Hautes Études Commerciales de Paris.

François Lamy currently works as a Director for the Association Française contre les Myopathies.